Together, our work extensively defined the cellular phenotypes of ATLL-associated PLCG1 mutations and provided an underlying molecular mechanism that explains their capacity to promote oncogenesis. This evidence concerns the gene PLCG1 and adult T-cell leukemia/lymphoma.